Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 43 | 2023 | 3639 | 4.820 |
Why?
|
Metabolomics | 45 | 2024 | 1487 | 4.750 |
Why?
|
Metabolome | 30 | 2023 | 894 | 3.640 |
Why?
|
Proteome | 19 | 2023 | 1794 | 2.750 |
Why?
|
Blood Proteins | 10 | 2023 | 1125 | 2.680 |
Why?
|
Amino Acids, Branched-Chain | 10 | 2023 | 251 | 2.320 |
Why?
|
Cardiovascular Diseases | 40 | 2023 | 15142 | 2.190 |
Why?
|
Aptamers, Nucleotide | 4 | 2020 | 166 | 1.860 |
Why?
|
Diabetes Mellitus, Type 2 | 24 | 2023 | 11729 | 1.330 |
Why?
|
Guanidines | 2 | 2019 | 193 | 1.220 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2021 | 858 | 1.160 |
Why?
|
Carnitine | 7 | 2022 | 245 | 1.150 |
Why?
|
Mass Spectrometry | 24 | 2021 | 2203 | 1.150 |
Why?
|
Exercise | 18 | 2023 | 5611 | 1.140 |
Why?
|
High-Throughput Screening Assays | 6 | 2020 | 944 | 1.130 |
Why?
|
Metabolic Networks and Pathways | 7 | 2021 | 783 | 1.040 |
Why?
|
Cardiovascular System | 3 | 2023 | 828 | 1.040 |
Why?
|
Insulin Resistance | 19 | 2023 | 3863 | 1.030 |
Why?
|
Genome-Wide Association Study | 25 | 2023 | 12259 | 0.970 |
Why?
|
Diabetes Mellitus | 8 | 2023 | 5752 | 0.970 |
Why?
|
Leukotriene B4 | 5 | 2009 | 294 | 0.900 |
Why?
|
Aortic Valve Stenosis | 6 | 2023 | 1955 | 0.850 |
Why?
|
Monocytes | 13 | 2017 | 2593 | 0.830 |
Why?
|
Metabolic Diseases | 5 | 2019 | 658 | 0.830 |
Why?
|
Receptors, Leukotriene B4 | 4 | 2007 | 94 | 0.830 |
Why?
|
Atherosclerosis | 13 | 2022 | 3445 | 0.830 |
Why?
|
Blood Glucose | 14 | 2023 | 6259 | 0.830 |
Why?
|
Plasma | 4 | 2023 | 575 | 0.810 |
Why?
|
Immunoassay | 5 | 2020 | 751 | 0.810 |
Why?
|
Chemokine CCL2 | 6 | 2012 | 620 | 0.790 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 59 | 0.780 |
Why?
|
Coronary Disease | 5 | 2022 | 6078 | 0.770 |
Why?
|
Chromatography, Liquid | 15 | 2019 | 975 | 0.750 |
Why?
|
Tandem Mass Spectrometry | 10 | 2022 | 1156 | 0.720 |
Why?
|
SELEX Aptamer Technique | 1 | 2019 | 19 | 0.720 |
Why?
|
Humans | 231 | 2024 | 743811 | 0.700 |
Why?
|
Keto Acids | 1 | 2019 | 34 | 0.700 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2017 | 1265 | 0.690 |
Why?
|
Cyanides | 5 | 2023 | 83 | 0.660 |
Why?
|
Triglycerides | 10 | 2023 | 2453 | 0.630 |
Why?
|
Myocardial Infarction | 16 | 2023 | 11708 | 0.630 |
Why?
|
Pentanoic Acids | 1 | 2017 | 15 | 0.630 |
Why?
|
Betaine | 4 | 2021 | 86 | 0.630 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2015 | 688 | 0.580 |
Why?
|
Genomics | 5 | 2022 | 5714 | 0.570 |
Why?
|
Tricarboxylic Acids | 1 | 2016 | 29 | 0.550 |
Why?
|
S-Adenosylhomocysteine | 1 | 2016 | 41 | 0.550 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2011 | 1187 | 0.550 |
Why?
|
Animals | 91 | 2023 | 168660 | 0.540 |
Why?
|
Heart Failure | 12 | 2022 | 10896 | 0.530 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2015 | 1503 | 0.530 |
Why?
|
2-Aminoadipic Acid | 2 | 2022 | 33 | 0.510 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2016 | 109 | 0.510 |
Why?
|
Troponin I | 5 | 2015 | 619 | 0.510 |
Why?
|
Quantitative Trait Loci | 7 | 2023 | 2018 | 0.510 |
Why?
|
Endothelium, Vascular | 13 | 2020 | 4459 | 0.500 |
Why?
|
Liver | 8 | 2019 | 7479 | 0.500 |
Why?
|
Obesity | 18 | 2023 | 12744 | 0.500 |
Why?
|
Uremia | 3 | 2015 | 200 | 0.480 |
Why?
|
Aminoisobutyric Acids | 1 | 2014 | 37 | 0.480 |
Why?
|
Risk Factors | 45 | 2023 | 72252 | 0.480 |
Why?
|
Phenotype | 22 | 2023 | 16361 | 0.470 |
Why?
|
Echocardiography | 5 | 2021 | 5096 | 0.470 |
Why?
|
Male | 110 | 2023 | 349776 | 0.470 |
Why?
|
Middle Aged | 80 | 2023 | 213241 | 0.470 |
Why?
|
Chemotaxis, Leukocyte | 5 | 2008 | 675 | 0.460 |
Why?
|
Aptamers, Peptide | 4 | 2022 | 28 | 0.460 |
Why?
|
Mice | 57 | 2023 | 81154 | 0.460 |
Why?
|
Female | 116 | 2023 | 380020 | 0.460 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2016 | 581 | 0.460 |
Why?
|
Arginine | 2 | 2022 | 943 | 0.460 |
Why?
|
Coronary Artery Disease | 6 | 2023 | 6485 | 0.450 |
Why?
|
Myocardium | 6 | 2019 | 4775 | 0.450 |
Why?
|
Antibodies | 5 | 2022 | 2459 | 0.450 |
Why?
|
Predictive Value of Tests | 15 | 2020 | 15067 | 0.450 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2014 | 844 | 0.440 |
Why?
|
Purines | 2 | 2016 | 590 | 0.440 |
Why?
|
Bile Acids and Salts | 2 | 2014 | 368 | 0.440 |
Why?
|
Energy Metabolism | 7 | 2021 | 2899 | 0.440 |
Why?
|
Kidney Failure, Chronic | 4 | 2015 | 2534 | 0.430 |
Why?
|
Angina Pectoris | 2 | 2014 | 977 | 0.430 |
Why?
|
Longitudinal Studies | 14 | 2022 | 13980 | 0.430 |
Why?
|
Genetic Variation | 7 | 2021 | 6535 | 0.430 |
Why?
|
Hypertension, Pulmonary | 4 | 2018 | 1534 | 0.430 |
Why?
|
Ventricular Remodeling | 3 | 2022 | 1225 | 0.430 |
Why?
|
Myocytes, Cardiac | 8 | 2022 | 1631 | 0.420 |
Why?
|
Reproducibility of Results | 17 | 2023 | 19894 | 0.410 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 7 | 2006 | 707 | 0.410 |
Why?
|
Adipose Tissue, White | 2 | 2014 | 351 | 0.400 |
Why?
|
Case-Control Studies | 20 | 2022 | 21733 | 0.400 |
Why?
|
Antidotes | 4 | 2023 | 138 | 0.400 |
Why?
|
Nitric Oxide | 3 | 2021 | 2132 | 0.400 |
Why?
|
Amino Acids | 6 | 2023 | 1733 | 0.390 |
Why?
|
Aged | 58 | 2023 | 163178 | 0.390 |
Why?
|
Kynurenine | 3 | 2021 | 139 | 0.390 |
Why?
|
Cholesterol, HDL | 9 | 2022 | 1813 | 0.380 |
Why?
|
Prediabetic State | 4 | 2021 | 499 | 0.380 |
Why?
|
Glucose Tolerance Test | 6 | 2015 | 1151 | 0.380 |
Why?
|
Leukocytes | 4 | 2021 | 2044 | 0.370 |
Why?
|
Chemokine CXCL10 | 2 | 2009 | 305 | 0.370 |
Why?
|
Glucose | 10 | 2023 | 4398 | 0.360 |
Why?
|
Adipose Tissue, Brown | 3 | 2023 | 756 | 0.360 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2021 | 1537 | 0.350 |
Why?
|
AMP-Activated Protein Kinases | 6 | 2019 | 610 | 0.350 |
Why?
|
Fibroblast Growth Factors | 4 | 2022 | 878 | 0.350 |
Why?
|
Benzopyrans | 1 | 2009 | 63 | 0.350 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2023 | 15518 | 0.350 |
Why?
|
Stroke | 7 | 2023 | 9975 | 0.350 |
Why?
|
Myocardial Ischemia | 5 | 2023 | 2150 | 0.350 |
Why?
|
Myocardial Contraction | 2 | 2014 | 1579 | 0.350 |
Why?
|
Kynurenic Acid | 1 | 2009 | 46 | 0.350 |
Why?
|
Carboxylic Acids | 1 | 2009 | 97 | 0.340 |
Why?
|
Chemokines, CXC | 3 | 2006 | 422 | 0.340 |
Why?
|
Mice, Inbred C57BL | 25 | 2023 | 21824 | 0.340 |
Why?
|
Sarcosine | 2 | 2021 | 16 | 0.340 |
Why?
|
Kinetics | 5 | 2023 | 6476 | 0.330 |
Why?
|
Metabolism | 2 | 2011 | 196 | 0.330 |
Why?
|
Adult | 51 | 2023 | 213889 | 0.330 |
Why?
|
Cell Adhesion | 11 | 2009 | 3144 | 0.330 |
Why?
|
Incidence | 15 | 2023 | 20948 | 0.330 |
Why?
|
Chemistry, Clinical | 1 | 2009 | 63 | 0.330 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2023 | 476 | 0.330 |
Why?
|
Amino Acids, Aromatic | 3 | 2013 | 32 | 0.330 |
Why?
|
Muscle, Skeletal | 6 | 2023 | 4925 | 0.320 |
Why?
|
Gene Deletion | 4 | 2019 | 2749 | 0.320 |
Why?
|
Diet | 10 | 2022 | 7930 | 0.320 |
Why?
|
Adipose Tissue | 4 | 2022 | 3280 | 0.320 |
Why?
|
Interleukins | 2 | 2009 | 791 | 0.320 |
Why?
|
Choline | 2 | 2021 | 492 | 0.310 |
Why?
|
Zebrafish | 7 | 2022 | 2995 | 0.310 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2009 | 153 | 0.310 |
Why?
|
Apolipoproteins E | 8 | 2017 | 1436 | 0.310 |
Why?
|
Blood | 1 | 2010 | 596 | 0.300 |
Why?
|
Induced Pluripotent Stem Cells | 6 | 2022 | 1733 | 0.300 |
Why?
|
Computational Biology | 8 | 2022 | 3515 | 0.300 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1968 | 0.300 |
Why?
|
Cohort Studies | 24 | 2023 | 40545 | 0.300 |
Why?
|
Anthracyclines | 3 | 2022 | 288 | 0.290 |
Why?
|
Data Mining | 2 | 2020 | 537 | 0.290 |
Why?
|
Weight Loss | 3 | 2021 | 2625 | 0.280 |
Why?
|
Heart Injuries | 1 | 2008 | 210 | 0.280 |
Why?
|
Aortic Aneurysm | 1 | 2011 | 644 | 0.280 |
Why?
|
Endothelial Cells | 4 | 2021 | 3482 | 0.280 |
Why?
|
Genome, Human | 3 | 2021 | 4418 | 0.270 |
Why?
|
Glyoxylates | 2 | 2023 | 10 | 0.270 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 670 | 0.270 |
Why?
|
Risk Assessment | 15 | 2023 | 23327 | 0.270 |
Why?
|
Biomedical Technology | 1 | 2008 | 220 | 0.270 |
Why?
|
Intra-Abdominal Fat | 2 | 2022 | 591 | 0.270 |
Why?
|
Cell Line | 15 | 2020 | 15993 | 0.270 |
Why?
|
Aortic Rupture | 1 | 2009 | 312 | 0.270 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 535 | 0.260 |
Why?
|
Leukocytes, Mononuclear | 3 | 2017 | 1836 | 0.260 |
Why?
|
Lipid Metabolism | 6 | 2021 | 1885 | 0.260 |
Why?
|
Lipids | 5 | 2022 | 3307 | 0.260 |
Why?
|
Diabetes, Gestational | 1 | 2015 | 1184 | 0.260 |
Why?
|
Signal Transduction | 17 | 2023 | 23398 | 0.260 |
Why?
|
Insulin | 10 | 2023 | 6584 | 0.250 |
Why?
|
Asthma | 5 | 2024 | 6010 | 0.250 |
Why?
|
Adipocytes, White | 3 | 2017 | 89 | 0.250 |
Why?
|
Mice, Knockout | 19 | 2023 | 14563 | 0.240 |
Why?
|
Doxorubicin | 4 | 2022 | 2234 | 0.240 |
Why?
|
Lactic Acid | 4 | 2022 | 1131 | 0.240 |
Why?
|
Receptors, Purinergic P2 | 1 | 2005 | 153 | 0.240 |
Why?
|
Proteins | 3 | 2022 | 6098 | 0.240 |
Why?
|
Prospective Studies | 29 | 2023 | 53250 | 0.240 |
Why?
|
Macrophages | 5 | 2012 | 5651 | 0.240 |
Why?
|
Growth Differentiation Factor 10 | 1 | 2023 | 4 | 0.240 |
Why?
|
Coronary Sinus | 3 | 2019 | 87 | 0.230 |
Why?
|
T-Lymphocytes | 5 | 2007 | 10179 | 0.230 |
Why?
|
Receptors, Cell Surface | 4 | 2012 | 2865 | 0.230 |
Why?
|
Dyslipidemias | 4 | 2016 | 851 | 0.230 |
Why?
|
Barth Syndrome | 1 | 2023 | 25 | 0.220 |
Why?
|
Alzheimer Disease | 5 | 2023 | 8035 | 0.220 |
Why?
|
Homeostasis | 8 | 2023 | 3337 | 0.220 |
Why?
|
Oleic Acids | 1 | 2023 | 70 | 0.220 |
Why?
|
Sickle Cell Trait | 1 | 2023 | 81 | 0.220 |
Why?
|
MicroRNAs | 5 | 2024 | 3750 | 0.220 |
Why?
|
Natriuretic Peptide, Brain | 6 | 2021 | 1572 | 0.220 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2018 | 2200 | 0.220 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3047 | 0.220 |
Why?
|
Cells, Cultured | 16 | 2021 | 19232 | 0.220 |
Why?
|
Physical Endurance | 2 | 2023 | 370 | 0.220 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 314 | 0.220 |
Why?
|
Massachusetts | 7 | 2021 | 8660 | 0.220 |
Why?
|
Logistic Models | 10 | 2021 | 13404 | 0.220 |
Why?
|
Ketoglutaric Acids | 2 | 2022 | 78 | 0.220 |
Why?
|
Nucleosides | 2 | 2022 | 138 | 0.220 |
Why?
|
Body Mass Index | 10 | 2022 | 12718 | 0.210 |
Why?
|
Gastric Bypass | 1 | 2011 | 812 | 0.210 |
Why?
|
Hep G2 Cells | 3 | 2018 | 393 | 0.210 |
Why?
|
Adipocytes, Brown | 2 | 2014 | 144 | 0.200 |
Why?
|
Proportional Hazards Models | 7 | 2022 | 12354 | 0.200 |
Why?
|
Oxygen Consumption | 4 | 2023 | 1869 | 0.200 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2021 | 90 | 0.200 |
Why?
|
Peptide Fragments | 6 | 2021 | 5096 | 0.200 |
Why?
|
Risk | 6 | 2021 | 9677 | 0.200 |
Why?
|
Brugada Syndrome | 1 | 2022 | 98 | 0.200 |
Why?
|
Stroke Volume | 6 | 2022 | 5002 | 0.200 |
Why?
|
Poisoning | 1 | 2023 | 249 | 0.200 |
Why?
|
Adipocytes | 2 | 2019 | 1182 | 0.200 |
Why?
|
Homoarginine | 1 | 2021 | 9 | 0.200 |
Why?
|
Orotic Acid | 1 | 2021 | 23 | 0.200 |
Why?
|
Phenylalanine | 3 | 2023 | 365 | 0.200 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.190 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 177 | 0.190 |
Why?
|
Spermine | 1 | 2021 | 70 | 0.190 |
Why?
|
Brain Ischemia | 2 | 2013 | 3264 | 0.190 |
Why?
|
Life Style | 3 | 2021 | 3833 | 0.190 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5033 | 0.190 |
Why?
|
Heart | 3 | 2023 | 4460 | 0.190 |
Why?
|
Cholesterol | 6 | 2017 | 2922 | 0.190 |
Why?
|
Uridine | 1 | 2021 | 146 | 0.180 |
Why?
|
Protective Agents | 1 | 2021 | 156 | 0.180 |
Why?
|
Polyamines | 1 | 2021 | 120 | 0.180 |
Why?
|
Cell Differentiation | 6 | 2017 | 11478 | 0.180 |
Why?
|
Methylamines | 1 | 2021 | 122 | 0.180 |
Why?
|
Glycerophosphates | 1 | 2020 | 48 | 0.180 |
Why?
|
Interferon-gamma | 1 | 2009 | 3205 | 0.180 |
Why?
|
Fatty Liver | 3 | 2021 | 728 | 0.180 |
Why?
|
Interleukin-8 | 2 | 2022 | 690 | 0.180 |
Why?
|
Cystatin C | 1 | 2021 | 249 | 0.180 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2022 | 139 | 0.180 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2019 | 1222 | 0.180 |
Why?
|
E-Selectin | 4 | 2002 | 579 | 0.180 |
Why?
|
Tunica Intima | 1 | 2002 | 463 | 0.180 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2021 | 235 | 0.170 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 25032 | 0.170 |
Why?
|
Body Composition | 2 | 2019 | 2401 | 0.170 |
Why?
|
Chemokines | 2 | 2021 | 968 | 0.170 |
Why?
|
Glycolysis | 3 | 2021 | 830 | 0.170 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2022 | 690 | 0.170 |
Why?
|
Malates | 1 | 2019 | 33 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2022 | 555 | 0.170 |
Why?
|
Proline | 1 | 2021 | 457 | 0.170 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 967 | 0.170 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2019 | 85 | 0.160 |
Why?
|
Potassium Cyanide | 1 | 2018 | 16 | 0.160 |
Why?
|
Organ Specificity | 2 | 2014 | 2008 | 0.160 |
Why?
|
Thrombospondins | 1 | 2019 | 200 | 0.160 |
Why?
|
Succinic Acid | 1 | 2019 | 82 | 0.160 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2016 | 644 | 0.160 |
Why?
|
Viruses | 1 | 2022 | 374 | 0.160 |
Why?
|
Activin Receptors, Type II | 1 | 2019 | 127 | 0.160 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 217 | 0.160 |
Why?
|
Cytosine | 1 | 2019 | 216 | 0.160 |
Why?
|
Odds Ratio | 8 | 2020 | 9848 | 0.160 |
Why?
|
Citric Acid Cycle | 1 | 2019 | 231 | 0.160 |
Why?
|
Prognosis | 11 | 2021 | 29052 | 0.160 |
Why?
|
Kidney Function Tests | 3 | 2020 | 684 | 0.160 |
Why?
|
Vascular Resistance | 3 | 2018 | 936 | 0.160 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2018 | 57 | 0.160 |
Why?
|
Rats | 8 | 2022 | 24250 | 0.160 |
Why?
|
Overweight | 2 | 2021 | 2371 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2022 | 329 | 0.150 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2021 | 436 | 0.150 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9440 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2022 | 2938 | 0.150 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2017 | 32 | 0.150 |
Why?
|
Specimen Handling | 1 | 2022 | 694 | 0.150 |
Why?
|
American Heart Association | 3 | 2017 | 1057 | 0.150 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2023 | 805 | 0.150 |
Why?
|
Heredity | 1 | 2017 | 154 | 0.150 |
Why?
|
Aged, 80 and over | 15 | 2023 | 57744 | 0.150 |
Why?
|
Gait | 2 | 2022 | 795 | 0.150 |
Why?
|
Receptors, Thrombin | 2 | 1995 | 131 | 0.150 |
Why?
|
Body Constitution | 1 | 2017 | 278 | 0.150 |
Why?
|
Protein Array Analysis | 2 | 2009 | 411 | 0.150 |
Why?
|
Proteoglycans | 1 | 2020 | 837 | 0.150 |
Why?
|
Lung | 4 | 2024 | 9858 | 0.150 |
Why?
|
Intracranial Embolism | 1 | 2019 | 202 | 0.150 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 2877 | 0.150 |
Why?
|
Diffusion of Innovation | 2 | 2019 | 725 | 0.150 |
Why?
|
Tea | 1 | 2018 | 274 | 0.150 |
Why?
|
Kidney | 5 | 2020 | 7185 | 0.150 |
Why?
|
Diet, Reducing | 2 | 2021 | 462 | 0.150 |
Why?
|
Follow-Up Studies | 14 | 2022 | 39001 | 0.140 |
Why?
|
Automation | 1 | 2019 | 584 | 0.140 |
Why?
|
Antibody Affinity | 1 | 2017 | 254 | 0.140 |
Why?
|
Platelet Activation | 1 | 2020 | 674 | 0.140 |
Why?
|
Xanthines | 1 | 2016 | 121 | 0.140 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2018 | 365 | 0.140 |
Why?
|
Ribonucleosides | 1 | 2016 | 82 | 0.140 |
Why?
|
Adaptation, Physiological | 1 | 2023 | 1311 | 0.140 |
Why?
|
Time Factors | 16 | 2019 | 40038 | 0.140 |
Why?
|
Alanine | 1 | 2018 | 571 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17439 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2022 | 458 | 0.140 |
Why?
|
Sensitivity and Specificity | 6 | 2019 | 14714 | 0.130 |
Why?
|
Arteriosclerosis | 1 | 2000 | 1092 | 0.130 |
Why?
|
Aging | 4 | 2023 | 8655 | 0.130 |
Why?
|
Dimethylglycine Dehydrogenase | 1 | 2015 | 2 | 0.130 |
Why?
|
Disease Models, Animal | 11 | 2023 | 18027 | 0.130 |
Why?
|
Amines | 1 | 2017 | 276 | 0.130 |
Why?
|
Isocitrates | 1 | 2015 | 24 | 0.130 |
Why?
|
Molecular Structure | 2 | 2011 | 1894 | 0.130 |
Why?
|
Cardiotoxins | 1 | 2015 | 41 | 0.130 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2015 | 86 | 0.130 |
Why?
|
Taurocholic Acid | 1 | 2015 | 43 | 0.130 |
Why?
|
Rodent Diseases | 1 | 2015 | 57 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3769 | 0.130 |
Why?
|
Lipolysis | 2 | 2014 | 210 | 0.130 |
Why?
|
Gene Targeting | 2 | 2011 | 879 | 0.130 |
Why?
|
Databases, Factual | 2 | 2023 | 7729 | 0.130 |
Why?
|
United States | 17 | 2023 | 69859 | 0.130 |
Why?
|
Flow Cytometry | 8 | 2011 | 5973 | 0.130 |
Why?
|
Heart Diseases | 3 | 2019 | 2789 | 0.130 |
Why?
|
Mobility Limitation | 1 | 2019 | 409 | 0.120 |
Why?
|
Ablation Techniques | 1 | 2017 | 249 | 0.120 |
Why?
|
Renal Dialysis | 3 | 2015 | 1783 | 0.120 |
Why?
|
Fatty Acids | 3 | 2023 | 1809 | 0.120 |
Why?
|
Models, Genetic | 3 | 2022 | 3492 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2019 | 2504 | 0.120 |
Why?
|
Dermatitis, Atopic | 1 | 2021 | 654 | 0.120 |
Why?
|
DNA, Single-Stranded | 1 | 2016 | 354 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2020 | 1030 | 0.120 |
Why?
|
Mice, 129 Strain | 2 | 2014 | 386 | 0.120 |
Why?
|
Carotid Artery Diseases | 2 | 2018 | 875 | 0.120 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2015 | 197 | 0.120 |
Why?
|
Oxidation-Reduction | 3 | 2017 | 2183 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 361 | 0.120 |
Why?
|
Tryptophan Hydroxylase | 1 | 2014 | 89 | 0.120 |
Why?
|
Peroxidase | 2 | 2016 | 611 | 0.120 |
Why?
|
Actinin | 2 | 2006 | 160 | 0.120 |
Why?
|
Sterol Regulatory Element Binding Proteins | 2 | 2011 | 27 | 0.120 |
Why?
|
Caffeine | 1 | 2018 | 699 | 0.120 |
Why?
|
Information Dissemination | 1 | 2022 | 1099 | 0.120 |
Why?
|
Gene Frequency | 2 | 2022 | 3585 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2015 | 194 | 0.120 |
Why?
|
Cholesterol, LDL | 3 | 2022 | 2354 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11524 | 0.110 |
Why?
|
Thrombin | 3 | 2002 | 598 | 0.110 |
Why?
|
Cholesterol Esters | 1 | 2013 | 74 | 0.110 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 700 | 0.110 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2015 | 227 | 0.110 |
Why?
|
Parabiosis | 1 | 2013 | 65 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2022 | 1373 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.110 |
Why?
|
Receptors, LDL | 1 | 2015 | 477 | 0.110 |
Why?
|
Heterocyclic Compounds | 1 | 2014 | 248 | 0.110 |
Why?
|
Parathion | 1 | 2012 | 14 | 0.110 |
Why?
|
Pulmonary Circulation | 1 | 2016 | 739 | 0.110 |
Why?
|
Endophenotypes | 1 | 2015 | 250 | 0.110 |
Why?
|
Receptors, CCR2 | 2 | 2005 | 212 | 0.110 |
Why?
|
Thrombosis | 3 | 2020 | 2968 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 781 | 0.110 |
Why?
|
Heart Atria | 1 | 2019 | 1357 | 0.110 |
Why?
|
Riboflavin | 1 | 2013 | 108 | 0.110 |
Why?
|
Transaminases | 1 | 2013 | 200 | 0.110 |
Why?
|
Forecasting | 2 | 2019 | 2950 | 0.110 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1195 | 0.110 |
Why?
|
Growth Differentiation Factors | 1 | 2013 | 98 | 0.110 |
Why?
|
Genetic Association Studies | 1 | 2022 | 2703 | 0.110 |
Why?
|
PPAR alpha | 1 | 2014 | 198 | 0.110 |
Why?
|
Tissue Culture Techniques | 1 | 2013 | 291 | 0.110 |
Why?
|
Smoking | 3 | 2020 | 8984 | 0.100 |
Why?
|
Collagen | 1 | 2021 | 2681 | 0.100 |
Why?
|
Serum Albumin | 1 | 2015 | 675 | 0.100 |
Why?
|
Chemokines, CC | 2 | 2005 | 290 | 0.100 |
Why?
|
Health | 1 | 2015 | 394 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1199 | 0.100 |
Why?
|
Osteopontin | 1 | 2013 | 294 | 0.100 |
Why?
|
Carbohydrates | 1 | 2014 | 394 | 0.100 |
Why?
|
Cytokines | 2 | 2018 | 7324 | 0.100 |
Why?
|
NAD | 1 | 2015 | 590 | 0.100 |
Why?
|
Chromatography, Gas | 1 | 2011 | 156 | 0.100 |
Why?
|
Mice, Transgenic | 6 | 2016 | 9731 | 0.100 |
Why?
|
Immunohistochemistry | 5 | 2012 | 11360 | 0.100 |
Why?
|
Up-Regulation | 3 | 2017 | 4221 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1005 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2009 | 1159 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2014 | 389 | 0.100 |
Why?
|
Nutritional Status | 2 | 2020 | 1608 | 0.100 |
Why?
|
Leukocytosis | 1 | 2013 | 247 | 0.100 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2019 | 277 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Postprandial Period | 1 | 2013 | 293 | 0.100 |
Why?
|
I-kappa B Kinase | 2 | 2011 | 252 | 0.100 |
Why?
|
Gastrointestinal Motility | 1 | 2013 | 225 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1859 | 0.100 |
Why?
|
Adiposity | 2 | 2019 | 1806 | 0.100 |
Why?
|
Peptide Mapping | 1 | 2011 | 263 | 0.100 |
Why?
|
ROC Curve | 3 | 2021 | 3527 | 0.100 |
Why?
|
Culture Media, Conditioned | 2 | 2022 | 537 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2016 | 575 | 0.100 |
Why?
|
Exercise Test | 2 | 2011 | 2074 | 0.100 |
Why?
|
Nucleotides | 2 | 2012 | 463 | 0.100 |
Why?
|
Statistics as Topic | 2 | 2016 | 2369 | 0.100 |
Why?
|
Pregnancy Trimester, First | 1 | 2015 | 853 | 0.090 |
Why?
|
Biological Assay | 2 | 2011 | 650 | 0.090 |
Why?
|
Cisplatin | 1 | 2017 | 1662 | 0.090 |
Why?
|
Child Nutrition Disorders | 1 | 2012 | 149 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1360 | 0.090 |
Why?
|
Troponin T | 2 | 2016 | 754 | 0.090 |
Why?
|
Databases, Genetic | 1 | 2017 | 1782 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.090 |
Why?
|
Biogenic Amines | 1 | 2010 | 50 | 0.090 |
Why?
|
Young Adult | 7 | 2023 | 56392 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2011 | 560 | 0.090 |
Why?
|
Kininogens | 1 | 2009 | 19 | 0.090 |
Why?
|
Physical Conditioning, Animal | 1 | 2014 | 354 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 70 | 0.090 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 871 | 0.090 |
Why?
|
Dicarboxylic Acids | 1 | 2010 | 69 | 0.090 |
Why?
|
Cardiomegaly | 1 | 2013 | 621 | 0.090 |
Why?
|
Aorta | 2 | 2009 | 2062 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3175 | 0.090 |
Why?
|
Adipokines | 2 | 2022 | 320 | 0.090 |
Why?
|
Umbilical Veins | 3 | 2000 | 433 | 0.090 |
Why?
|
Angiotensin II | 2 | 2011 | 880 | 0.090 |
Why?
|
Sphingomyelins | 1 | 2010 | 106 | 0.090 |
Why?
|
Podocytes | 2 | 2020 | 396 | 0.090 |
Why?
|
Program Development | 1 | 2016 | 1314 | 0.090 |
Why?
|
Indicator Dilution Techniques | 1 | 2009 | 40 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 814 | 0.090 |
Why?
|
Diglycerides | 2 | 2021 | 176 | 0.090 |
Why?
|
Serum Amyloid P-Component | 1 | 2009 | 47 | 0.090 |
Why?
|
Area Under Curve | 3 | 2021 | 1654 | 0.090 |
Why?
|
Rabbits | 4 | 2017 | 4894 | 0.090 |
Why?
|
Linear Models | 2 | 2020 | 5952 | 0.090 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2022 | 1813 | 0.090 |
Why?
|
DNA, Complementary | 2 | 2004 | 2050 | 0.090 |
Why?
|
Pulmonary Artery | 1 | 2018 | 1911 | 0.090 |
Why?
|
Microfilament Proteins | 2 | 2006 | 1152 | 0.090 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 3794 | 0.090 |
Why?
|
Oxyquinoline | 2 | 2008 | 15 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 440 | 0.090 |
Why?
|
Tryptophan | 2 | 2021 | 478 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7719 | 0.080 |
Why?
|
Glucose Intolerance | 2 | 2016 | 577 | 0.080 |
Why?
|
Rats, Wistar | 1 | 2013 | 1892 | 0.080 |
Why?
|
Nerve Growth Factors | 1 | 2012 | 574 | 0.080 |
Why?
|
Kidney Diseases | 3 | 2013 | 2146 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2019 | 1574 | 0.080 |
Why?
|
Gene Expression | 4 | 2021 | 7793 | 0.080 |
Why?
|
Genotype | 7 | 2020 | 12944 | 0.080 |
Why?
|
Electrocardiography | 3 | 2019 | 6441 | 0.080 |
Why?
|
Isotopes | 1 | 2008 | 124 | 0.080 |
Why?
|
X-Ray Microtomography | 1 | 2011 | 428 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 2945 | 0.080 |
Why?
|
Aortic Valve | 3 | 2023 | 1920 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.080 |
Why?
|
Breast Neoplasms | 5 | 2019 | 20827 | 0.080 |
Why?
|
Gene Transfer Techniques | 3 | 1999 | 1224 | 0.080 |
Why?
|
Treatment Outcome | 11 | 2023 | 63042 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1008 | 0.080 |
Why?
|
Rheology | 1 | 2009 | 345 | 0.080 |
Why?
|
Fasting | 4 | 2019 | 1590 | 0.080 |
Why?
|
Constipation | 1 | 2013 | 546 | 0.080 |
Why?
|
Docosahexaenoic Acids | 1 | 2015 | 877 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
Dietary Proteins | 2 | 2012 | 962 | 0.080 |
Why?
|
Cell Lineage | 2 | 2015 | 2506 | 0.080 |
Why?
|
Chromatography, Affinity | 1 | 2009 | 549 | 0.080 |
Why?
|
Lipoproteins | 3 | 2018 | 881 | 0.080 |
Why?
|
Inosine | 2 | 2022 | 133 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3965 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 838 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2017 | 5078 | 0.080 |
Why?
|
Isotope Labeling | 1 | 2009 | 405 | 0.080 |
Why?
|
Cell Migration Inhibition | 1 | 2007 | 96 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2020 | 1525 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 819 | 0.070 |
Why?
|
Adenoviridae | 3 | 2002 | 1100 | 0.070 |
Why?
|
Longevity | 1 | 2015 | 1070 | 0.070 |
Why?
|
Osteonectin | 1 | 2006 | 34 | 0.070 |
Why?
|
Leucine | 2 | 2023 | 559 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3513 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10394 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5854 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12243 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1537 | 0.070 |
Why?
|
Peptide Library | 1 | 2008 | 349 | 0.070 |
Why?
|
Motor Activity | 2 | 2015 | 2714 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3917 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2015 | 13691 | 0.070 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2009 | 449 | 0.070 |
Why?
|
Neovascularization, Physiologic | 2 | 2015 | 1351 | 0.070 |
Why?
|
Chemotaxis | 1 | 2009 | 607 | 0.070 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 262 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1364 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 211 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 405 | 0.070 |
Why?
|
Heart Transplantation | 1 | 2019 | 3113 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 524 | 0.070 |
Why?
|
Pyruvate Kinase | 1 | 2008 | 189 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4665 | 0.070 |
Why?
|
Chemokine CCL19 | 1 | 2005 | 35 | 0.070 |
Why?
|
Phenols | 1 | 2010 | 496 | 0.070 |
Why?
|
Inflammation | 6 | 2023 | 10629 | 0.070 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 889 | 0.070 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 626 | 0.070 |
Why?
|
Jurkat Cells | 2 | 1998 | 743 | 0.070 |
Why?
|
Pyruvic Acid | 2 | 2022 | 200 | 0.070 |
Why?
|
Swine | 3 | 2023 | 5909 | 0.070 |
Why?
|
Citric Acid | 1 | 2005 | 126 | 0.070 |
Why?
|
Lethal Dose 50 | 2 | 2017 | 77 | 0.070 |
Why?
|
Fibronectins | 1 | 2009 | 726 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4749 | 0.060 |
Why?
|
Alleles | 2 | 2015 | 6934 | 0.060 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 237 | 0.060 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2007 | 471 | 0.060 |
Why?
|
Transcription Factors | 4 | 2023 | 12209 | 0.060 |
Why?
|
Sulfones | 1 | 2007 | 434 | 0.060 |
Why?
|
Pregnancy | 3 | 2015 | 29140 | 0.060 |
Why?
|
Comorbidity | 3 | 2015 | 10380 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1023 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2016 | 1911 | 0.060 |
Why?
|
Metagenomics | 2 | 2020 | 428 | 0.060 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 795 | 0.060 |
Why?
|
Growth Differentiation Factor 15 | 2 | 2016 | 176 | 0.060 |
Why?
|
China | 2 | 2022 | 2243 | 0.060 |
Why?
|
Ticlopidine | 1 | 2010 | 899 | 0.060 |
Why?
|
C-Reactive Protein | 4 | 2021 | 3778 | 0.060 |
Why?
|
Causality | 1 | 2011 | 1275 | 0.060 |
Why?
|
Waist Circumference | 2 | 2022 | 917 | 0.060 |
Why?
|
Aorta, Abdominal | 1 | 2007 | 646 | 0.060 |
Why?
|
Phosphorylation | 3 | 2021 | 8436 | 0.060 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2019 | 563 | 0.060 |
Why?
|
Glycine | 2 | 2018 | 670 | 0.060 |
Why?
|
Transfection | 3 | 2015 | 5892 | 0.060 |
Why?
|
Galectin 3 | 2 | 2016 | 228 | 0.060 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2007 | 637 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10940 | 0.060 |
Why?
|
Antigens, Ly | 1 | 2005 | 290 | 0.060 |
Why?
|
Chemokine CCL5 | 1 | 2004 | 209 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3503 | 0.060 |
Why?
|
Adenosine Monophosphate | 1 | 2005 | 275 | 0.060 |
Why?
|
RNA Interference | 2 | 2010 | 2890 | 0.060 |
Why?
|
Biomedical Research | 2 | 2016 | 3308 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.060 |
Why?
|
Weight Gain | 1 | 2014 | 2294 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2005 | 465 | 0.060 |
Why?
|
Lipoprotein Lipase | 1 | 2023 | 127 | 0.060 |
Why?
|
Ketones | 2 | 2019 | 187 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1637 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2023 | 48 | 0.060 |
Why?
|
Cardiolipins | 1 | 2023 | 88 | 0.060 |
Why?
|
Hypertension | 3 | 2020 | 8480 | 0.060 |
Why?
|
Hepatocytes | 2 | 2022 | 1211 | 0.060 |
Why?
|
False Negative Reactions | 1 | 2004 | 588 | 0.060 |
Why?
|
PPAR gamma | 2 | 2019 | 492 | 0.060 |
Why?
|
Glucuronates | 1 | 2022 | 40 | 0.060 |
Why?
|
Mesenteric Arteries | 1 | 2003 | 183 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4839 | 0.060 |
Why?
|
Hemopexin | 1 | 2022 | 33 | 0.060 |
Why?
|
Chemotactic Factors | 1 | 2003 | 199 | 0.050 |
Why?
|
Adenosine Triphosphate | 2 | 2020 | 2029 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1800 | 0.050 |
Why?
|
Models, Cardiovascular | 1 | 2008 | 996 | 0.050 |
Why?
|
Deoxycholic Acid | 1 | 2022 | 54 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 2337 | 0.050 |
Why?
|
Ligands | 3 | 2019 | 3281 | 0.050 |
Why?
|
Mice, Mutant Strains | 1 | 2006 | 1862 | 0.050 |
Why?
|
Ketoglutarate Dehydrogenase Complex | 1 | 2022 | 20 | 0.050 |
Why?
|
Lysophosphatidylcholines | 1 | 2022 | 81 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2008 | 1117 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1108 | 0.050 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2022 | 140 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 180 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4467 | 0.050 |
Why?
|
Reperfusion | 1 | 2023 | 283 | 0.050 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3660 | 0.050 |
Why?
|
Hemodynamics | 2 | 2023 | 4197 | 0.050 |
Why?
|
Apolipoproteins B | 1 | 2023 | 374 | 0.050 |
Why?
|
Pseudouridine | 1 | 2022 | 24 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2016 | 0.050 |
Why?
|
Guanosine | 1 | 2022 | 61 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2008 | 13028 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2006 | 4386 | 0.050 |
Why?
|
Cell Movement | 4 | 2011 | 5216 | 0.050 |
Why?
|
Serine | 1 | 2005 | 825 | 0.050 |
Why?
|
Systole | 2 | 2019 | 958 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1895 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2004 | 980 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2850 | 0.050 |
Why?
|
Lipase | 1 | 2023 | 314 | 0.050 |
Why?
|
Glycerol | 1 | 2022 | 278 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2022 | 281 | 0.050 |
Why?
|
Sulfonic Acids | 1 | 2021 | 97 | 0.050 |
Why?
|
Acyltransferases | 1 | 2023 | 294 | 0.050 |
Why?
|
Fish Products | 1 | 2021 | 29 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 420 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3758 | 0.050 |
Why?
|
Lactase | 1 | 2021 | 69 | 0.050 |
Why?
|
Protein Binding | 5 | 2009 | 9377 | 0.050 |
Why?
|
Mississippi | 1 | 2021 | 88 | 0.050 |
Why?
|
Glutamates | 1 | 2022 | 397 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2013 | 3591 | 0.050 |
Why?
|
Biology | 1 | 2023 | 295 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
Phosphatidylcholines | 1 | 2022 | 410 | 0.050 |
Why?
|
Disease Progression | 3 | 2016 | 13273 | 0.050 |
Why?
|
Cell Survival | 2 | 2016 | 5881 | 0.050 |
Why?
|
Rhinovirus | 1 | 2022 | 187 | 0.050 |
Why?
|
Molecular Probes | 1 | 2002 | 315 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 593 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2005 | 780 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 915 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 2647 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2010 | 2162 | 0.050 |
Why?
|
Oxidants | 1 | 2021 | 164 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.050 |
Why?
|
Peptides | 4 | 2009 | 4406 | 0.050 |
Why?
|
Vital Capacity | 1 | 2023 | 925 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
Meat Products | 1 | 2021 | 99 | 0.050 |
Why?
|
Interleukin-10 | 1 | 2006 | 1200 | 0.050 |
Why?
|
Glioblastoma | 1 | 2015 | 3480 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2022 | 389 | 0.050 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2002 | 717 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2012 | 1518 | 0.050 |
Why?
|
Population Density | 1 | 2021 | 196 | 0.050 |
Why?
|
Ischemic Preconditioning | 1 | 2021 | 92 | 0.050 |
Why?
|
Spirometry | 1 | 2023 | 863 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6773 | 0.050 |
Why?
|
P-Selectin | 2 | 2004 | 601 | 0.050 |
Why?
|
Dipeptidases | 1 | 2019 | 38 | 0.050 |
Why?
|
Phosphorylcholine | 1 | 2020 | 162 | 0.040 |
Why?
|
Mice, SCID | 2 | 2015 | 2718 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2001 | 241 | 0.040 |
Why?
|
Biological Transport | 2 | 2017 | 2119 | 0.040 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2020 | 76 | 0.040 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2019 | 58 | 0.040 |
Why?
|
Autoantibodies | 1 | 2008 | 2037 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2006 | 2560 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 2074 | 0.040 |
Why?
|
Dinoprostone | 1 | 2022 | 601 | 0.040 |
Why?
|
Immunoglobulin E | 2 | 2022 | 1463 | 0.040 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2019 | 86 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 279 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
Receptors, Leukocyte-Adhesion | 1 | 1999 | 53 | 0.040 |
Why?
|
Cell Membrane | 4 | 2004 | 3749 | 0.040 |
Why?
|
Taxoids | 2 | 2013 | 666 | 0.040 |
Why?
|
Botulinum Toxins | 1 | 2001 | 191 | 0.040 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2017 | 496 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2004 | 1552 | 0.040 |
Why?
|
Ribonucleotides | 1 | 2019 | 117 | 0.040 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2019 | 88 | 0.040 |
Why?
|
Cross Reactions | 1 | 2021 | 841 | 0.040 |
Why?
|
Adolescent | 6 | 2022 | 85729 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 247 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 391 | 0.040 |
Why?
|
Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
Norway | 1 | 2020 | 448 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15211 | 0.040 |
Why?
|
Mutagenesis | 2 | 2021 | 1263 | 0.040 |
Why?
|
Follistatin | 1 | 2019 | 141 | 0.040 |
Why?
|
Brachial Artery | 1 | 2020 | 369 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2009 | 0.040 |
Why?
|
Hyperplasia | 1 | 2002 | 1185 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 676 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2020 | 137 | 0.040 |
Why?
|
Child | 7 | 2024 | 77637 | 0.040 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 126 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2019 | 160 | 0.040 |
Why?
|
Diet Records | 1 | 2020 | 425 | 0.040 |
Why?
|
Acceleration | 1 | 2019 | 183 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 889 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2023 | 1740 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 435 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 569 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 2006 | 0.040 |
Why?
|
Integrin alpha4 | 1 | 1998 | 92 | 0.040 |
Why?
|
Introns | 2 | 2011 | 991 | 0.040 |
Why?
|
Medicare | 3 | 2021 | 6565 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 370 | 0.040 |
Why?
|
Base Sequence | 2 | 2011 | 12798 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4568 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 12066 | 0.040 |
Why?
|
Taurine | 1 | 2018 | 94 | 0.040 |
Why?
|
L-Selectin | 1 | 1998 | 214 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 188 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 697 | 0.040 |
Why?
|
Activins | 1 | 2019 | 208 | 0.040 |
Why?
|
Metformin | 2 | 2016 | 837 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5301 | 0.040 |
Why?
|
Sample Size | 1 | 2021 | 841 | 0.040 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
omega-N-Methylarginine | 1 | 2017 | 111 | 0.040 |
Why?
|
Mutation | 4 | 2021 | 29777 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3070 | 0.040 |
Why?
|
Structure-Activity Relationship | 3 | 2006 | 3128 | 0.040 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 264 | 0.040 |
Why?
|
Blood Pressure | 4 | 2015 | 8551 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1622 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2019 | 625 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 1374 | 0.040 |
Why?
|
Calcium Signaling | 1 | 2021 | 721 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 11059 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2509 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8316 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2020 | 798 | 0.040 |
Why?
|
Cysteine | 1 | 2021 | 871 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13112 | 0.040 |
Why?
|
Models, Biological | 2 | 2011 | 9582 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2022 | 4422 | 0.040 |
Why?
|
Piperazines | 1 | 2007 | 2487 | 0.040 |
Why?
|
Electron Transport Complex IV | 1 | 2017 | 189 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8637 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5264 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2021 | 986 | 0.040 |
Why?
|
Sulfur | 1 | 2017 | 166 | 0.040 |
Why?
|
Mice, Nude | 2 | 2017 | 3680 | 0.040 |
Why?
|
Frail Elderly | 1 | 2021 | 693 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6170 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2022 | 7880 | 0.040 |
Why?
|
Nutrigenomics | 1 | 2016 | 23 | 0.040 |
Why?
|
Lymphokines | 1 | 2019 | 948 | 0.040 |
Why?
|
Ultrasonography | 1 | 2009 | 5986 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 2134 | 0.030 |
Why?
|
Blotting, Western | 2 | 2020 | 5179 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1143 | 0.030 |
Why?
|
Vasodilation | 1 | 2020 | 944 | 0.030 |
Why?
|
Glycogen | 1 | 2016 | 259 | 0.030 |
Why?
|
Amino Acid Sequence | 4 | 2009 | 13809 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1998 | 257 | 0.030 |
Why?
|
Histidine | 1 | 2017 | 312 | 0.030 |
Why?
|
Adrenomedullin | 1 | 2016 | 87 | 0.030 |
Why?
|
Pentosyltransferases | 1 | 2015 | 65 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3645 | 0.030 |
Why?
|
Body Fat Distribution | 1 | 2017 | 244 | 0.030 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2016 | 55 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2021 | 12020 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2011 | 18107 | 0.030 |
Why?
|
Diet Surveys | 1 | 2020 | 1173 | 0.030 |
Why?
|
Muscle Cells | 1 | 2016 | 197 | 0.030 |
Why?
|
Creatinine | 1 | 2021 | 1918 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1205 | 0.030 |
Why?
|
1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2015 | 10 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2018 | 595 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1002 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2018 | 589 | 0.030 |
Why?
|
Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1108 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1181 | 0.030 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2015 | 162 | 0.030 |
Why?
|
Extremities | 1 | 2020 | 867 | 0.030 |
Why?
|
Genome | 1 | 2023 | 1806 | 0.030 |
Why?
|
Food | 1 | 2020 | 771 | 0.030 |
Why?
|
Atrial Natriuretic Factor | 1 | 2016 | 393 | 0.030 |
Why?
|
Ceramides | 1 | 2016 | 199 | 0.030 |
Why?
|
Glycopeptides | 1 | 2016 | 226 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6237 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 369 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2017 | 657 | 0.030 |
Why?
|
Indoles | 1 | 2023 | 1841 | 0.030 |
Why?
|
Apoptosis | 2 | 2013 | 9718 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4204 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2022 | 5524 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2006 | 3106 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2638 | 0.030 |
Why?
|
Dietary Supplements | 2 | 2018 | 3292 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2015 | 251 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8856 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2779 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3701 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2803 | 0.030 |
Why?
|
Glutarates | 1 | 2015 | 236 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1632 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1903 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 709 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2015 | 642 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 348 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1674 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9272 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2012 | 2712 | 0.030 |
Why?
|
Down-Regulation | 2 | 2017 | 3000 | 0.030 |
Why?
|
Glipizide | 1 | 2013 | 47 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 964 | 0.030 |
Why?
|
Finland | 1 | 2015 | 602 | 0.030 |
Why?
|
Child of Impaired Parents | 1 | 2017 | 455 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 269 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 430 | 0.030 |
Why?
|
Pralidoxime Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 2012 | 6 | 0.030 |
Why?
|
Emetine | 1 | 2012 | 15 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.030 |
Why?
|
Neoplasms | 2 | 2015 | 21675 | 0.030 |
Why?
|
Metoclopramide | 1 | 2012 | 51 | 0.030 |
Why?
|
Glycopyrrolate | 1 | 2012 | 33 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2016 | 723 | 0.030 |
Why?
|
Nitroprusside | 1 | 2013 | 275 | 0.030 |
Why?
|
Isoleucine | 1 | 2012 | 112 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2267 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2167 | 0.030 |
Why?
|
Neostigmine | 1 | 2012 | 69 | 0.030 |
Why?
|
Organometallic Compounds | 2 | 2008 | 665 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1335 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2008 | 2085 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1826 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2002 | 3421 | 0.030 |
Why?
|
Lysine | 1 | 2017 | 1007 | 0.030 |
Why?
|
Pirenzepine | 1 | 2012 | 115 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8300 | 0.030 |
Why?
|
Atropine | 1 | 2012 | 244 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.030 |
Why?
|
Microscopy, Fluorescence | 3 | 2005 | 2692 | 0.030 |
Why?
|
Xenopus | 1 | 1994 | 712 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 506 | 0.030 |
Why?
|
Protein Precursors | 1 | 2016 | 1154 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 103 | 0.030 |
Why?
|
Cholinergic Antagonists | 1 | 2012 | 165 | 0.020 |
Why?
|
Sirolimus | 1 | 2019 | 1565 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2015 | 1342 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1725 | 0.020 |
Why?
|
Troponin C | 1 | 2011 | 25 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2013 | 454 | 0.020 |
Why?
|
Primates | 1 | 2013 | 545 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1876 | 0.020 |
Why?
|
Valine | 1 | 2012 | 413 | 0.020 |
Why?
|
Manometry | 1 | 2013 | 445 | 0.020 |
Why?
|
Internet | 1 | 2023 | 3058 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 742 | 0.020 |
Why?
|
Prekallikrein | 1 | 2009 | 11 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1656 | 0.020 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2010 | 30 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2931 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2112 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 52 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1102 | 0.020 |
Why?
|
Amino Acid Transport Systems | 1 | 2010 | 32 | 0.020 |
Why?
|
Workflow | 1 | 2015 | 847 | 0.020 |
Why?
|
Autoradiography | 1 | 2011 | 745 | 0.020 |
Why?
|
Glucose Metabolism Disorders | 1 | 2010 | 54 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 984 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2021 | 77410 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 137 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2005 | 2327 | 0.020 |
Why?
|
Sampling Studies | 1 | 2011 | 622 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2015 | 906 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3336 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1994 | 2839 | 0.020 |
Why?
|
Legionellosis | 1 | 1989 | 11 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6750 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2298 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1642 | 0.020 |
Why?
|
Pyridines | 1 | 2001 | 2827 | 0.020 |
Why?
|
Systems Integration | 1 | 2011 | 440 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2862 | 0.020 |
Why?
|
Splenectomy | 1 | 2011 | 394 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2634 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4189 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2916 | 0.020 |
Why?
|
Glutamine | 1 | 2012 | 579 | 0.020 |
Why?
|
Intracellular Space | 1 | 2010 | 210 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10251 | 0.020 |
Why?
|
Sirtuins | 1 | 2011 | 323 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 1995 | 3772 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2899 | 0.020 |
Why?
|
North America | 1 | 2012 | 1249 | 0.020 |
Why?
|
Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2760 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2015 | 850 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4326 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2011 | 1202 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2002 | 3503 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 513 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2012 | 16674 | 0.020 |
Why?
|
Extracellular Space | 1 | 2010 | 595 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 1996 | 1542 | 0.020 |
Why?
|
Brain | 2 | 2023 | 26345 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2010 | 432 | 0.020 |
Why?
|
Autophagy | 1 | 2015 | 1296 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15526 | 0.020 |
Why?
|
Water Supply | 1 | 1989 | 214 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6311 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3547 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
Tissue Donors | 1 | 2017 | 2241 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 1996 | 1272 | 0.020 |
Why?
|
Antigens, CD | 1 | 1998 | 4026 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2566 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2013 | 851 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1479 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1691 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 935 | 0.020 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2007 | 101 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3817 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4670 | 0.020 |
Why?
|
Actins | 2 | 2006 | 2121 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10477 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2016 | 1880 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2007 | 264 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 2006 | 203 | 0.020 |
Why?
|
Breast | 1 | 2015 | 1970 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2001 | 3255 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6759 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 12788 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2217 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2008 | 480 | 0.020 |
Why?
|
Chromatography | 1 | 2005 | 206 | 0.020 |
Why?
|
Basement Membrane | 1 | 2006 | 357 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4552 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1781 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2008 | 633 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2008 | 844 | 0.020 |
Why?
|
Colon | 1 | 2013 | 1772 | 0.020 |
Why?
|
Protein Sorting Signals | 1 | 2005 | 281 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2005 | 114 | 0.020 |
Why?
|
Trypsin | 1 | 2005 | 511 | 0.020 |
Why?
|
Health Surveys | 1 | 2015 | 4036 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8337 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2005 | 429 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3510 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9336 | 0.010 |
Why?
|
Stem Cells | 2 | 2009 | 3566 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3622 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2378 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 35409 | 0.010 |
Why?
|
Databases, Protein | 1 | 2005 | 383 | 0.010 |
Why?
|
Lectins | 1 | 2005 | 513 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2008 | 1684 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4251 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 534 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2086 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 1536 | 0.010 |
Why?
|
Pipecolic Acids | 1 | 2002 | 76 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2006 | 1185 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1581 | 0.010 |
Why?
|
ADP Ribose Transferases | 1 | 2001 | 90 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2003 | 768 | 0.010 |
Why?
|
U937 Cells | 1 | 2001 | 268 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2004 | 689 | 0.010 |
Why?
|
Models, Molecular | 2 | 2005 | 5445 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6356 | 0.010 |
Why?
|
Infant | 1 | 2022 | 35122 | 0.010 |
Why?
|
Proteinuria | 1 | 2003 | 658 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1263 | 0.010 |
Why?
|
Cross Infection | 1 | 1989 | 1416 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2002 | 688 | 0.010 |
Why?
|
Phagocytosis | 1 | 2005 | 1539 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2646 | 0.010 |
Why?
|
Perfusion | 1 | 2004 | 1359 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2005 | 1127 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7908 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5532 | 0.010 |
Why?
|
Homozygote | 1 | 2003 | 1787 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2003 | 1586 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2005 | 1986 | 0.010 |
Why?
|
Pneumonia | 1 | 1989 | 2133 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2438 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2764 | 0.010 |
Why?
|
Integrins | 1 | 2001 | 846 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 5021 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2077 | 0.010 |
Why?
|
Heart Rate | 1 | 2007 | 4091 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2008 | 4576 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12786 | 0.010 |
Why?
|
Protein Transport | 1 | 2001 | 1988 | 0.010 |
Why?
|
Hospitals | 1 | 1989 | 3953 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2003 | 1837 | 0.010 |
Why?
|
Lymphocytes | 1 | 2003 | 2615 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 40964 | 0.010 |
Why?
|
Bone Marrow | 1 | 2005 | 2951 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9648 | 0.010 |
Why?
|
Polymers | 1 | 2001 | 1621 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2002 | 6380 | 0.010 |
Why?
|
Carcinoma | 1 | 2005 | 2375 | 0.010 |
Why?
|
NF-kappa B | 1 | 2002 | 2500 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8430 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1996 | 788 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2003 | 4561 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9944 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7295 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1995 | 1802 | 0.010 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1989 | 115 | 0.010 |
Why?
|
Virginia | 1 | 1989 | 121 | 0.010 |
Why?
|
Water Microbiology | 1 | 1989 | 117 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 1996 | 1439 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1995 | 4183 | 0.000 |
Why?
|
Environmental Monitoring | 1 | 1989 | 1413 | 0.000 |
Why?
|
Disease Outbreaks | 1 | 1989 | 1771 | 0.000 |
Why?
|